VE1 immunohistochemistry in pituitary adenomas is not associated with BRAF V600E mutation

被引：19
|
作者：
Sperveslage, Jan [2 ]
Gierke, Midea [1 ]
Capper, David [3 ]
Honegger, Juergen [4 ]
Sipos, Bence [2 ]
Beschorner, Rudi [1 ]
Schittenhelm, Jens [1 ]
机构：
[1] Univ Tubingen, Dept Neuropathol, D-72076 Tubingen, Germany
[2] Univ Tubingen, Inst Pathol, D-72076 Tubingen, Germany
[3] Heidelberg Univ, German Canc Res Ctr DKFZ, Dept Neuropathol, Clin Cooperat Unit Neuropathol, Heidelberg, Germany
[4] Univ Tubingen, Dept Neurosurg, D-72076 Tubingen, Germany
来源：
ACTA NEUROPATHOLOGICA | 2013年 / 125卷 / 06期
关键词：
Adenoma; Thyroid Carcinoma; Pituitary Adenoma; Papillary Thyroid Carcinoma; Hairy Cell Leukemia;
D O I：
10.1007/s00401-013-1118-5
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：911 / 912
页数：2
相关论文
共 50 条
  • [31] Potential Pitfalls in the Detection of BRAF V600E Mutation By Immunohistochemistry
    John, I. V. Y.
    Valente, Alfredo
    Tull, Jamie
    Maciak, Charlene
    Zhang, Shengle
    MODERN PATHOLOGY, 2015, 28 : 515A - 516A
  • [32] Determination of BRAF V600E (VE1) protein expression and BRAF gene mutation status in codon 600 in borderline and low-grade ovarian cancers
    Sadlecki, Pawel
    Walentowicz, Pawel
    Bodnar, Magdalena
    Marszalek, Andrzej
    Grabiec, Marek
    Walentowicz-Sadlecka, Malgorzata
    TUMOR BIOLOGY, 2017, 39 (05)
  • [33] BRAF VE1 Immunoreactivity Distinguishes Ameloblastoma from Keratocystic Odontogenic Tumor and Dentigerous Cyst, and Correlates with BRAF V600E Mutation Status
    Mendez, Luvy Delfin
    Wolsefer, Nicholas
    Asa, Sylvia
    Couce, Marta
    Wasman, Jay
    Yoest, Jennifer
    Stojanov, Ivan
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 766 - 767
  • [34] BRAF VE1 Immunoreactivity Distinguishes Ameloblastoma from Keratocystic Odontogenic Tumor and Dentigerous Cyst, and Correlates with BRAF V600E Mutation Status
    Mendez, Luvy Delfin
    Wolsefer, Nicholas
    Asa, Sylvia
    Couce, Marta
    Wasman, Jay
    Yoest, Jennifer
    Stojanov, Ivan
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 766 - 767
  • [35] Correlation between immunohistochemistry using anti-BRAF V600E (VE1) antibody, and BRAF V600E mutation by RT-PCR with COBAS 4800 in Papillary Thyroid Carcinoma (PTC): A study of twenty-six cases
    Etxezarraga, M. C.
    Zufiaurre, M.
    Ugalde, A.
    Nieto, J. A.
    Solano, J. D.
    VIRCHOWS ARCHIV, 2015, 467 : S70 - S70
  • [36] VE1 (BRAF V600E) immunohistochemistry in colorectal cancer: Validation, assessment of heterogeneity and clinicopathological associations in three colorectal cancer cohorts
    Schafroth, C.
    Galvan, J. A.
    Sokol, L.
    Rieger, G.
    Dawson, H. E.
    Koelzer, V. H.
    Langer, R.
    Lugli, A.
    Zlobec, I.
    VIRCHOWS ARCHIV, 2015, 467 : S44 - S44
  • [37] Detection of BRAF V600E mutations in skin metastases of malignant melanoma by monoclonal antibody VE1
    Skorokhod, Alexander
    Capper, David
    von Deimling, Andreas
    Enk, Alexander
    Helmbold, Peter
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 67 (03) : 488 - 491
  • [38] Immunohistochemical expression profiles of BRAF (V600E/VE1) in serrated colon polyps in Turkish population
    Kokenek-Unal, Tuba D.
    Senel, Fatma
    Gurcay, Nesrin
    Tasdemir, Arzu
    Coban, Ipek
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (08): : 8868 - 8874
  • [39] BRAF V600E Immunohistochemistry in Colorectal Carcinoma
    Estrella, J. S.
    Tetzlaff, M. T.
    Kazen, C.
    Kopetz, S.
    Maru, D. M.
    Rashid, A.
    Hamilton, S. R.
    Broaddus, R. R.
    MODERN PATHOLOGY, 2014, 27 : 173A - 173A
  • [40] BRAF V600E Immunohistochemistry in Colorectal Carcinoma
    Estrella, J. S.
    Tetzlaff, M. T.
    Kazen, C.
    Kopetz, S.
    Maru, D. M.
    Rashid, A.
    Hamilton, S. R.
    Broaddus, R. R.
    LABORATORY INVESTIGATION, 2014, 94 : 173A - 173A
12345